Preparation of 188Re-HEDP as a bone tumor radionuclide therapeutic-Reference-Cited by-同舟云学术

Preparation of 188Re-HEDP as a bone tumor radionuclide therapeutic

Published:2022-12-31 Issue:03 Volume:68 Page:277-278
ISSN:1857-8969
Container-title:Macedonian Pharmaceutical Bulletin
language:en
Short-container-title:Maced. Pharm. Bull.

Author:

Tripunoski Toni¹,Ugrinska Ana¹,Kuzmanovska Sonja¹

Affiliation:

1. Institute of Pathophysiology and Nuclear Medicine, Medical Faculty, Ss Cyril and Methodius University, Mother Teresa 17, 1000 Skopje, Republic of North Macedonia

Publisher

Macedonian Pharmaceutical Association

Subject

General Medicine

Link

https://bulletin.mfd.org.mk/volumes/Volume%2068_3/68_3_133.pdf

Reference7 articles.

1. Deutsch, E., Libson, K., Vanderheyden, J., Alan, R., Maxon, R.H., 1986. The Chemistry of Rhenium and Techenetium as Related to the Use of Isotopes of these Elements in Therapeutic and Diagnostic Nuclear Medicine. Nucl. Med. Biol. 13(4), 465-477. https://doi.org/10.101610883-2897(86)90027-9

2. Kothari, K., Pillai, M.R., Unni, P.R., Shimpi, H.H., Noronha, O.P., Samuel, A.M., 1999. Preparation, stability studies and pharmacological behavior of [186Re] Re-HEDP. Applied Radiation and Isotopes 51, 51-58. https://doi.org/10.1016/S0969-8043(98)00195-X

3. Lee, J.S., Lee, J.S., Park, U.J., Son, K.J., Han, H.S., 2009. Development of a high performance 188W/188Re generator using synthetic alumina. Appl Radiat Isot. 67, 1162–1166. https://doi.org/10.1016/j.apradiso.2009.02.062

4. Lepareur, N., Lacoeuille, F., Bouvry, C., Hindré, F., Garcion, E., Chérel, M., Noiret, N., Garin, E., Knapp, F.F.R. JR., 2019. Rhenium-188 Labeled Radiopharmaceuticals: Current Clinical Applications in Oncology and Promising Perspectives. Front. Med. 6, 132. https://doi.org/10.3389/fmed.2019.00132

5. Liepe, K., 2018. 188Re-HEDP therapy in the therapy of painful bone metastases. World J. Nuc.l Med. 17, 133-138. https://doi.org/10.4103/wjnm.WJNM_85_17